Reagents Sales Propel GenMark's Q3 Revenues up 162 Percent

In addition to a 164 percent increase in reagent revenues to $581,000, GenMark also posted $72,000 in instruments and other product revenues, compared to none in the year-ago period.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories